<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35627250</PMID><DateCompleted><Year>2022</Year><Month>05</Month><Day>31</Day></DateCompleted><DateRevised><Year>2022</Year><Month>07</Month><Day>16</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2073-4425</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>5</Issue><PubDate><Year>2022</Year><Month>May</Month><Day>12</Day></PubDate></JournalIssue><Title>Genes</Title><ISOAbbreviation>Genes (Basel)</ISOAbbreviation></Journal><ArticleTitle>Lessons to Learn from the Gut Microbiota: A Focus on Amyotrophic Lateral Sclerosis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">865</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/genes13050865</ELocationID><Abstract><AbstractText>The gut microbiota is able to modulate the development and homeostasis of the central nervous system (CNS) through the immune, circulatory, and neuronal systems. In turn, the CNS influences the gut microbiota through stress responses and at the level of the endocrine system. This bidirectional communication forms the "gut microbiota-brain axis" and has been postulated to play a role in the etiopathology of several neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS). Numerous studies in animal models of ALS and in patients have highlighted the close communication between the immune system and the gut microbiota and, therefore, it is possible that alterations in the gut microbiota may have a direct impact on neuronal function and survival in ALS patients. Consequently, if the gut dysbiosis does indeed play a role in ALS-related neurodegeneration, nutritional immunomodulatory interventions based on probiotics, prebiotics, and/or postbiotics could emerge as innovative therapeutic strategies. This review aimed to shed light on the impact of the gut microbiota in ALS disease and on the use of potential nutritional interventions based on different types of biotics to ameliorate ALS symptoms.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Calvo</LastName><ForeName>Ana Cristina</ForeName><Initials>AC</Initials><Identifier Source="ORCID">0000-0001-5193-7782</Identifier><AffiliationInfo><Affiliation>Department of Anatomy, Agroalimentary Institute of Aragon (IA2), Embryology and Animal Genetics, University of Zaragoza, Calle Miguel Servet 13, 50013 Zaragoza, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valledor-Mart&#xed;n</LastName><ForeName>In&#xe9;s</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Anatomy, Agroalimentary Institute of Aragon (IA2), Embryology and Animal Genetics, University of Zaragoza, Calle Miguel Servet 13, 50013 Zaragoza, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moreno-Mart&#xed;nez</LastName><ForeName>Laura</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-7277-4318</Identifier><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Enfermedades Neurodegenerativas (CIBERNED), Aragon Institute for Health Research (IIS Aragon), Calle Miguel Servet 13, 50013 Zaragoza, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Toivonen</LastName><ForeName>Janne Markus</ForeName><Initials>JM</Initials><Identifier Source="ORCID">0000-0002-7243-1737</Identifier><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Enfermedades Neurodegenerativas (CIBERNED), Aragon Institute for Health Research (IIS Aragon), Calle Miguel Servet 13, 50013 Zaragoza, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Osta</LastName><ForeName>Rosario</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-5687-6704</Identifier><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Enfermedades Neurodegenerativas (CIBERNED), Aragon Institute for Health Research (IIS Aragon), Calle Miguel Servet 13, 50013 Zaragoza, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>05</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Genes (Basel)</MedlineTA><NlmUniqueID>101551097</NlmUniqueID><ISSNLinking>2073-4425</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D056692">Prebiotics</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064806" MajorTopicYN="N">Dysbiosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069196" MajorTopicYN="Y">Gastrointestinal Microbiome</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056692" MajorTopicYN="N">Prebiotics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019936" MajorTopicYN="Y">Probiotics</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">gut dysbiosis</Keyword><Keyword MajorTopicYN="N">gut microbiota</Keyword><Keyword MajorTopicYN="N">postbiotics</Keyword><Keyword MajorTopicYN="N">prebiotics</Keyword><Keyword MajorTopicYN="N">probiotics</Keyword><Keyword MajorTopicYN="N">transgenic SOD1G93A mice</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>3</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>5</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>5</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>5</Month><Day>28</Day><Hour>1</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>5</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>6</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35627250</ArticleId><ArticleId IdType="pmc">PMC9140531</ArticleId><ArticleId IdType="doi">10.3390/genes13050865</ArticleId><ArticleId IdType="pii">genes13050865</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Pasinelli P., Brown R.H. Molecular biology of amyotrophic lateral sclerosis: Insights from genetics. Nat. Rev. Neurosci. 2006;7:710&#x2013;723. doi: 10.1038/nrn1971.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn1971</ArticleId><ArticleId IdType="pubmed">16924260</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJes&#xfa;s-Hern&#xe1;ndez M., Mackenzie I.R., Boeve B.F., Boxer A.L., Baker M., Rutherford N.J., Nicholson A.N., Finch N.A., Flynn H., Adamson J., et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron. 2011;72:245&#x2013;256. doi: 10.1016/j.neuron.2011.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.011</ArticleId><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton A.E., Chi&#xf2; A., Traynor B.J. State of play in amyotrophic lateral sclerosis genetics. Nat. Neurosci. 2014;17:17&#x2013;23. doi: 10.1038/nn.3584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3584</ArticleId><ArticleId IdType="pmc">PMC4544832</ArticleId><ArticleId IdType="pubmed">24369373</ArticleId></ArticleIdList></Reference><Reference><Citation>Vucic S., Kiernan C. Pathophysiology of neurodegeneration in familial amyotrophic lateral sclerosis. Curr. Mol. Med. 2009;9:255&#x2013;272. doi: 10.2174/156652409787847173.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/156652409787847173</ArticleId><ArticleId IdType="pubmed">19355908</ArticleId></ArticleIdList></Reference><Reference><Citation>Logroscino G., Traynor B.J., Hardiman O., Chi&#xf2; A., Mitchell D., Swingler R.J., Millul A., Benn E., Begh E., EURALS Incidence of Amyotrophic Lateral Sclerosis in Europe. J. Neurol. Neurosurg. Psychiatry. 2010;81:385&#x2013;390. doi: 10.1136/jnnp.2009.183525.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2009.183525</ArticleId><ArticleId IdType="pmc">PMC2850819</ArticleId><ArticleId IdType="pubmed">19710046</ArticleId></ArticleIdList></Reference><Reference><Citation>Uenal H., Rosenbohm A., Kufeldt J., Weydt P., Goder K., Ludolph A., Rothenbacher D., Nagel G., ALS registry Study Group Incidence and Geographical Variation of Amyotrophic Lateral Sclerosis (ALS) in Southern Germany &#x2013;Completeness of the ALS Registry Swabia. PLoS ONE. 2014;9:e93932. doi: 10.1371/journal.pone.0093932.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0093932</ArticleId><ArticleId IdType="pmc">PMC3983245</ArticleId><ArticleId IdType="pubmed">24722455</ArticleId></ArticleIdList></Reference><Reference><Citation>Wijesekera L.C., Leigh P.N. Amyotrophic lateral sclerosis. Orphanet J. Rare Dis. 2009;4:3. doi: 10.1186/1750-1172-4-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1172-4-3</ArticleId><ArticleId IdType="pmc">PMC2656493</ArticleId><ArticleId IdType="pubmed">19192301</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho M.D., Swash M. Awaji diagnostic algorithm increases sensitivity of El Escorial criteria for ALS diagnosis. Amyotroph. Lateral Scler. 2009;10:53&#x2013;57. doi: 10.1080/17482960802521126.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17482960802521126</ArticleId><ArticleId IdType="pubmed">18985466</ArticleId></ArticleIdList></Reference><Reference><Citation>Finsterer J., St&#xf6;llberger C. Apply Awaji-shima Consensus Conference Criteria before Diagnosing Amyotrophic Lateral Sclerosis. Open Neurol. J. 2013;7:4&#x2013;6. doi: 10.2174/1874205X01307010004.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1874205X01307010004</ArticleId><ArticleId IdType="pmc">PMC3568883</ArticleId><ArticleId IdType="pubmed">23407618</ArticleId></ArticleIdList></Reference><Reference><Citation>Goutman S.A., Hardiman O., Al-Chalabi A., Chi&#xf3; A., Savelieff M.G., Kiernan M.C., Feldman E.L. Recent advances in the diagnosis and prognosis of amyotrophic lateral sclerosis. Lancet Neurol. 2022;21:480&#x2013;493. doi: 10.1016/S1474-4422(21)00465-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(21)00465-8</ArticleId><ArticleId IdType="pubmed">35334233</ArticleId></ArticleIdList></Reference><Reference><Citation>Balandra R., Jones A., Jivraj N., Knights C., Ellis C.M., Burman R., Turner M.R., Leigh P.N., Shaw C.E., Al-Chalabi A. Estimating clinical stage of amyotrophic lateral sclerosis from the ALS Functional Rating Scale. Amyotroph. Lateral Scler. Front. Degener. 2014;15:279&#x2013;284. doi: 10.3109/21678421.2014.897357.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2014.897357</ArticleId><ArticleId IdType="pubmed">24720420</ArticleId></ArticleIdList></Reference><Reference><Citation>El Mendili M.M., Cohen-Adad J., Pelegrini-Issac M., Rossignol S., Morizot-Koutlidis R., Marchand-Pauvert V., Iglesias C., Sangari S., Katz R., Lehericy S. Multi-Parametric Spinal Cord MRI as Potential Progression Marker in Amyotrophic Lateral Sclerosis. PLoS ONE. 2014;9:e95516. doi: 10.1371/journal.pone.0095516.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0095516</ArticleId><ArticleId IdType="pmc">PMC3995720</ArticleId><ArticleId IdType="pubmed">24755826</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurney M.E., Pu H., Chiu A.Y., Dal Canto M.C., Polchow C.Y., Alexander D.D., Caliendo J., Hentati A., Kwon Y.W., Deng H.X., et al. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science. 1994;264:1772&#x2013;1775. doi: 10.1126/science.8209258.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.8209258</ArticleId><ArticleId IdType="pubmed">8209258</ArticleId></ArticleIdList></Reference><Reference><Citation>Wachsmuth H.R., Weninger S.N., Duca F.A. Role of the gut-brain axis in energy and glucose metabolism. Exp. Mol. Med. 2022;54:377&#x2013;392. doi: 10.1038/s12276-021-00677-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s12276-021-00677-w</ArticleId><ArticleId IdType="pmc">PMC9076644</ArticleId><ArticleId IdType="pubmed">35474341</ArticleId></ArticleIdList></Reference><Reference><Citation>Jing Y., Bai F., Yu Y. Spinal cord injury and gut microbiota: A review. Life Sci. 2021;266:118865. doi: 10.1016/j.lfs.2020.118865.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2020.118865</ArticleId><ArticleId IdType="pubmed">33301807</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim C.H., Park J., Kim M. Gut Microbiota-Derived Short-Chain Fatty Acids, T Cells, and Inflammation. Immune Netw. 2014;14:277&#x2013;288. doi: 10.4110/in.2014.14.6.277.</Citation><ArticleIdList><ArticleId IdType="doi">10.4110/in.2014.14.6.277</ArticleId><ArticleId IdType="pmc">PMC4275385</ArticleId><ArticleId IdType="pubmed">25550694</ArticleId></ArticleIdList></Reference><Reference><Citation>Zondler L., M&#xfc;ller K., Khalaji S., Bliederh&#xe4;user C., Ruf W.P., Grozdanov V., Thiemann M., Fundel-Clemes K., Freischmidt A., Holzmann K., et al. Peripheral monocytes are functionally altered and invade the CNS in ALS patients. Acta Neuropathol. 2016;132:391&#x2013;411. doi: 10.1007/s00401-016-1548-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-016-1548-y</ArticleId><ArticleId IdType="pubmed">26910103</ArticleId></ArticleIdList></Reference><Reference><Citation>Ley R.E., Turnbaugh P.J., Klein S., Gordon J.I. Microbial ecology: Human gut microbes associated with obesity. Nature. 2006;444:1022&#x2013;1023. doi: 10.1038/4441022a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/4441022a</ArticleId><ArticleId IdType="pubmed">17183309</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhattacharjee S., Lukiw W.J. Alzheimer&#x2019;s disease and the microbiome. Front. Cell Neurosci. 2013;7:153. doi: 10.3389/fncel.2013.00153.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2013.00153</ArticleId><ArticleId IdType="pmc">PMC3775450</ArticleId><ArticleId IdType="pubmed">24062644</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins S.M. A role for the gut microbiota in IBS. Nat. Rev. Gastroenterol. Hepatol. 2014;11:497&#x2013;505. doi: 10.1038/nrgastro.2014.40.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrgastro.2014.40</ArticleId><ArticleId IdType="pubmed">24751910</ArticleId></ArticleIdList></Reference><Reference><Citation>Neish A.S. Microbes in gastrointestinal health and disease. Gastroenterology. 2009;136:65&#x2013;80. doi: 10.1053/j.gastro.2008.10.080.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2008.10.080</ArticleId><ArticleId IdType="pmc">PMC2892787</ArticleId><ArticleId IdType="pubmed">19026645</ArticleId></ArticleIdList></Reference><Reference><Citation>Thursby E., Juge N. Introduction to the human gut microbiota. Biochem. J. 2017;474:1823&#x2013;1836. doi: 10.1042/BCJ20160510.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BCJ20160510</ArticleId><ArticleId IdType="pmc">PMC5433529</ArticleId><ArticleId IdType="pubmed">28512250</ArticleId></ArticleIdList></Reference><Reference><Citation>Poretsky R., Rodriguez-R L.M., Luo C., Tsementzi D., Konstantinidis K.T. Strengths and limitations of 16S rRNA gene amplicon sequencing in revealing temporal microbial community dynamics. PLoS ONE. 2014;9:e93827. doi: 10.1371/journal.pone.0093827.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0093827</ArticleId><ArticleId IdType="pmc">PMC3979728</ArticleId><ArticleId IdType="pubmed">24714158</ArticleId></ArticleIdList></Reference><Reference><Citation>MicrobiomeBD.  [(accessed on 20 March 2022)].  Available online:  https://microbiomedb.org/mbio/app.</Citation></Reference><Reference><Citation>NIH Human Microbiome Project.  [(accessed on 20 March 2022)].  Available online:  https://hmpdacc.org.</Citation></Reference><Reference><Citation>MDB: Microbiome Database.  [(accessed on 20 March 2022)].  Available online:  https://db.cngb.org/microbiome.</Citation></Reference><Reference><Citation>Wang J., Lang T., Shen J., Dai J., Tian L., Wang X. Core Gut Bacteria Analysis of Healthy Mice. Front. Microbiol. 2019;10:887. doi: 10.3389/fmicb.2019.00887.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2019.00887</ArticleId><ArticleId IdType="pmc">PMC6491893</ArticleId><ArticleId IdType="pubmed">31105675</ArticleId></ArticleIdList></Reference><Reference><Citation>Sivan A., Corrales L., Hubert N., Williams J.B., Aquino-Michaels K., Earley Z.M., Benyamin F.W., Lei Y.M., Jabri B., Alegre M.L., et al. Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy. Science. 2015;350:1084&#x2013;1089. doi: 10.1126/science.aac4255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aac4255</ArticleId><ArticleId IdType="pmc">PMC4873287</ArticleId><ArticleId IdType="pubmed">26541606</ArticleId></ArticleIdList></Reference><Reference><Citation>Routy B., Le Chatelier E., Derosa L., Duong C.P.M., Alou M.T., Daillere R., Fluckiger A., Messaoudene M., Rauber C., Roberti M.P., et al. Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science. 2018;359:91&#x2013;97. doi: 10.1126/science.aan3706.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aan3706</ArticleId><ArticleId IdType="pubmed">29097494</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas L.V., Jenkins G., Belton J., Clements S., Jacob C., Johnson N., Joy D., Low J., Munson E., Sheppard J. Nutritional advice for community patients: Insights from a panel discussion. Br. J. Community Nurs. 2016;21:130&#x2013;137. doi: 10.12968/bjcn.2016.21.3.130.</Citation><ArticleIdList><ArticleId IdType="doi">10.12968/bjcn.2016.21.3.130</ArticleId><ArticleId IdType="pubmed">26940615</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh N., Gurav A., Sivaprakasam S., Brady E., Padia R., Shi H., Thangaraju M., Prasad P.D., Manicassamy S., Munn D.H., et al. Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis. Immunity. 2014;40:128&#x2013;139. doi: 10.1016/j.immuni.2013.12.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2013.12.007</ArticleId><ArticleId IdType="pmc">PMC4305274</ArticleId><ArticleId IdType="pubmed">24412617</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen N.D., D&#x2019;Aigle T., Gowing G., Julien J.P., Rivest S. Exacerbation of motor neuron disease by chronic stimulation of innate immunity in a mouse model of amyotrophic lateral sclerosis. J. Neurosci. 2004;24:1340&#x2013;1349. doi: 10.1523/JNEUROSCI.4786-03.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.4786-03.2004</ArticleId><ArticleId IdType="pmc">PMC6730331</ArticleId><ArticleId IdType="pubmed">14960605</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang C., Zhang M., Pang X., Zhao Y., Wang L., Zhao L. Structural resilience of the gut microbiota in adult mice under high-fat dietary perturbations. ISME J. 2012;6:1848&#x2013;1857. doi: 10.1038/ismej.2012.27.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ismej.2012.27</ArticleId><ArticleId IdType="pmc">PMC3446802</ArticleId><ArticleId IdType="pubmed">22495068</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodr&#xed;guez J.M., Murphy K., Stanton C., Ross R.P., Kober O.I., Juge N., Avershina E., Rudi K., Narbad A., Jenmalm M.C., et al. The composition of the gut microbiota throughout life, with an emphasis on early life. Microb. Ecol. Health Dis. 2015;26:26050. doi: 10.3402/mehd.v26.26050.</Citation><ArticleIdList><ArticleId IdType="doi">10.3402/mehd.v26.26050</ArticleId><ArticleId IdType="pmc">PMC4315782</ArticleId><ArticleId IdType="pubmed">25651996</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X., Liang S., Xia Z., Qu J., Liu H., Liu C., Yang H., Wang J., Madsen L., Hou Y., et al. Establishment of a Macaca fascicularis gut microbiome gene catalog and comparison with the human, pig, and mouse gut microbiomes. Gigascience. 2018;7:giy100. doi: 10.1093/gigascience/giy100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/gigascience/giy100</ArticleId><ArticleId IdType="pmc">PMC6137240</ArticleId><ArticleId IdType="pubmed">30137359</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu S., Yi J., Zhang Y.-G., Zhou J., Sun J. Leaky intestine and impaired microbiome in an amyotrophic lateral sclerosis mouse model. Physiol. Rep. 2015;3:e12356. doi: 10.14814/phy2.12356.</Citation><ArticleIdList><ArticleId IdType="doi">10.14814/phy2.12356</ArticleId><ArticleId IdType="pmc">PMC4425962</ArticleId><ArticleId IdType="pubmed">25847918</ArticleId></ArticleIdList></Reference><Reference><Citation>Winkler E.A., Sengillo J.D., Sagare A.P., Zhao Z., Ma Q., Zuniga E., Wang Y., Zhong Z., Sullivan J.S., Griffin J.H., et al. Blood-spinal cord barrier disruption contributes to early motor-neuron degeneration in ALS-model mice. Proc. Natl. Acad. Sci. USA. 2014;111:E1035&#x2013;E1042. doi: 10.1073/pnas.1401595111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1401595111</ArticleId><ArticleId IdType="pmc">PMC3964055</ArticleId><ArticleId IdType="pubmed">24591593</ArticleId></ArticleIdList></Reference><Reference><Citation>de La Serre C., de Lartigue G., Raybould H.E. Chronic exposure to low dose bacterial lipopolysaccharide inhibits leptin signaling in vagal afferent neurons. Physiol. Behav. 2015;139:188&#x2013;194. doi: 10.1016/j.physbeh.2014.10.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.physbeh.2014.10.032</ArticleId><ArticleId IdType="pmc">PMC4523075</ArticleId><ArticleId IdType="pubmed">25446227</ArticleId></ArticleIdList></Reference><Reference><Citation>McCombe P.A., Henderson R.D., Lee A., Lee J.D., Woodruff T.M., Restuadi R., McRae A., Wray N.R., Ngo S., Steyn F.J. Gut microbiota in ALS: Possible role in pathogenesis? Expert Rev. Neurother. 2019;19:785&#x2013;805. doi: 10.1080/14737175.2019.1623026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14737175.2019.1623026</ArticleId><ArticleId IdType="pubmed">31122082</ArticleId></ArticleIdList></Reference><Reference><Citation>Blacher E., Bashiardes S., Shapiro H., Rothschild D., Mor U., Dori-Bachash M., Kleimeyer C., Moresi C., Harnik Y., Zur M., et al. Potential roles of gut microbiome and metabolites in modulating ALS in mice. Nature. 2019;572:474&#x2013;480. doi: 10.1038/s41586-019-1443-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-019-1443-5</ArticleId><ArticleId IdType="pubmed">31330533</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y.G., Wu S., Yi J., Xia Y., Jin D., Zhou J., Sun J. Target Intestinal Microbiota to Alleviate Disease Progression in Amyotrophic Lateral Sclerosis. Clin. Ther. 2016;39:322&#x2013;336. doi: 10.1016/j.clinthera.2016.12.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinthera.2016.12.014</ArticleId></ArticleIdList></Reference><Reference><Citation>Gotkine M., Kviatcovsky D., Elinav E. Amyotrophic lateral sclerosis and intestinal microbiota-toward establishing cause and effect. Gut Microbes. 2020;11:1833&#x2013;1841. doi: 10.1080/19490976.2020.1767464.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19490976.2020.1767464</ArticleId><ArticleId IdType="pmc">PMC7524331</ArticleId><ArticleId IdType="pubmed">32501768</ArticleId></ArticleIdList></Reference><Reference><Citation>Figueroa-Romero C., Guo K., Murdocck B.J., Paez-Colasante X., Bassis C.M., Mikhail K.A., Raue K.D., Evans M.C., Taubman G.F., McDermott A.J., et al. Temporal evolution of the microbiome, immune system and epigenome with disease progression in ALS mice. Dis. Model. Mech. 2019;13:dmm041947. doi: 10.1242/dmm.041947.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.041947</ArticleId><ArticleId IdType="pmc">PMC6906635</ArticleId><ArticleId IdType="pubmed">31597644</ArticleId></ArticleIdList></Reference><Reference><Citation>Burberry A., Wells M.F., Limone F., Couto A., Smith K.S., Keaney J., Gillet G., van Gastel N., Wang J.Y., Pietilainen O., et al. C9orf72 suppresses systemic and neural inflammation induced by gut bacteria. Nature. 2020;582:89&#x2013;94. doi: 10.1038/s41586-020-2288-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2288-7</ArticleId><ArticleId IdType="pmc">PMC7416879</ArticleId><ArticleId IdType="pubmed">32483373</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang X., Wang X., Yang S., Meng F., Wang X., Wei H., Chen T. Evaluation of the microbial diversity in amyotrophic lateral sclerosis using high-throughput sequencing. Front. Microbiol. 2016;7:1479. doi: 10.3389/fmicb.2016.01479.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2016.01479</ArticleId><ArticleId IdType="pmc">PMC5028383</ArticleId><ArticleId IdType="pubmed">27703453</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowin J., Xia Y., Jung B., Sun J. Gut inflammation and dysbiosis in human motor neuron disease. Physiol. Rep. 2017;5:e13443. doi: 10.14814/phy2.13443.</Citation><ArticleIdList><ArticleId IdType="doi">10.14814/phy2.13443</ArticleId><ArticleId IdType="pmc">PMC5617930</ArticleId><ArticleId IdType="pubmed">28947596</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng Q., Shen J., Chen K., Zhou J., Liao Q., Lu K., Yuan J., Bi F. The alteration of gut microbiome and metabolism in amyotrophic lateral sclerosis patients. Sci. Rep. 2020;10:12998. doi: 10.1038/s41598-020-69845-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-69845-8</ArticleId><ArticleId IdType="pmc">PMC7398913</ArticleId><ArticleId IdType="pubmed">32747678</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhai C.D., Zheng J.J., An B.C., Huang H.F., Tan Z.C. Intestinal microbiota composition in patients with amyotrophic lateral sclerosis: Establishment of bacterial and archaeal communities analyses. Chin. Med. J. 2019;132:1815&#x2013;1822. doi: 10.1097/CM9.0000000000000351.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CM9.0000000000000351</ArticleId><ArticleId IdType="pmc">PMC6759115</ArticleId><ArticleId IdType="pubmed">31306225</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazzini L., Mogna L., De Marchi F., Amoruso A., Pane M., Aloisio I., Cionci N.B., Gagg&#xec;a F., Lucenti A., Bersano E., et al. Potential role of gut microbiota in ALS pathogenesis and possible novel therapeutic strategies. J. Clin. Gastroenterol. 2018;52((Suppl. 1)):S68&#x2013;S70. doi: 10.1097/MCG.0000000000001042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MCG.0000000000001042</ArticleId><ArticleId IdType="pubmed">29782468</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenner D., Hiergeist A., Adis C., Mayer B., Gessner A., Ludolph A.C., Weishaupt J.H. The fecal microbiome of ALS patients. Neurobiol. Aging. 2018;61:132&#x2013;137. doi: 10.1016/j.neurobiolaging.2017.09.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2017.09.023</ArticleId><ArticleId IdType="pubmed">29065369</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicholson K., Bjornevik K., Abu-Ali G., Chan J., Cortese M., Dedi B., Jeon M., Xavier R., Huttenhower C., Ascherio A., et al. The human gut microbiota in people with amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Front. Degener. 2021;22:186&#x2013;194. doi: 10.1080/21678421.2020.1828475.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2020.1828475</ArticleId></ArticleIdList></Reference><Reference><Citation>Olde Loohuis L.M., Mangul S., Ori A.P.S., Jospin G., Koslicki D., Yang H.T., Wu T., Boks M.P., Lomen-Hoerth C., Wiedau-Pazos M., et al. Transcriptome analysis in whole blood reveals increased microbial diversity in schizophrenia. Transl. Psychiatry. 2018;8:96. doi: 10.1038/s41398-018-0107-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41398-018-0107-9</ArticleId><ArticleId IdType="pmc">PMC5943399</ArticleId><ArticleId IdType="pubmed">29743478</ArticleId></ArticleIdList></Reference><Reference><Citation>Berer K., Mues M., Koutrolos M., Rasbi Z.A., Boziki M., Johner C., Wekerle H., Krishnamoorthy G. Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination. Nature. 2011;479:538&#x2013;541. doi: 10.1038/nature10554.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature10554</ArticleId><ArticleId IdType="pubmed">22031325</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheperjans F. Gut microbiota, 1013 new pieces in the Parkinson&#x2019;s disease puzzle. Curr. Opin. Neurol. 2016;29:773&#x2013;780. doi: 10.1097/WCO.0000000000000389.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WCO.0000000000000389</ArticleId><ArticleId IdType="pubmed">27653288</ArticleId></ArticleIdList></Reference><Reference><Citation>Benakis C., Brea D., Caballero S., Faraco G., Moore J., Murphy M., Sita G., Racchumi G., Ling L., Pamer E.G., et al. Commensal microbiota affects ischemic stroke outcome by regulating intestinal &#x3b3; &#x3b4; T cells. Nat. Med. 2016;22:516&#x2013;523. doi: 10.1038/nm.4068.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.4068</ArticleId><ArticleId IdType="pmc">PMC4860105</ArticleId><ArticleId IdType="pubmed">27019327</ArticleId></ArticleIdList></Reference><Reference><Citation>Pellegrini C., Antonioli L., Colucci R., Blandizzi C., Fornai M. Interplay among gut microbiota, intestinal mucosal barrier and enteric neuro-immune system: A common path to neurodegenerative diseases? Acta Neuropathol. 2018;136:345&#x2013;361. doi: 10.1007/s00401-018-1856-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-018-1856-5</ArticleId><ArticleId IdType="pubmed">29797112</ArticleId></ArticleIdList></Reference><Reference><Citation>Brodin J., Mild M., Hedskog C., Sherwood E., Leitner T., Andersson B., Albert J. PCR-Induced Transitions Are the Major Source of Error in Cleaned Ultra-Deep Pyrosequencing Data. PLoS ONE. 2013;8:e70388. doi: 10.1371/journal.pone.0070388.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0070388</ArticleId><ArticleId IdType="pmc">PMC3720931</ArticleId><ArticleId IdType="pubmed">23894647</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L., Zhuang Z., Zhang G., Huang T., Fan D. Assessment of bidirectional relationships between 98 genera of the human gut microbiota and amyotrophic lateral sclerosis: A 2-sample Mendelian randomization study. BMC Neurol. 2022;22:8. doi: 10.1186/s12883-021-02522-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12883-021-02522-z</ArticleId><ArticleId IdType="pmc">PMC8721912</ArticleId><ArticleId IdType="pubmed">34979977</ArticleId></ArticleIdList></Reference><Reference><Citation>Amyotrophic Lateral Sclerosis Association.  [(accessed on 21 March 2022)].  Available online:  https://www.als.org.</Citation></Reference><Reference><Citation>Caballero-Villarraso J., Galvan A., Escribano B.M., Tunez I. Interrelationships Among Gut Microbiota and Host: Paradigms, Role in Neurodegenerative Diseases and Future Prospects. CNS Neurol. Disord. Drug Targets. 2017;16:945&#x2013;964. doi: 10.2174/1871527316666170714120118.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1871527316666170714120118</ArticleId><ArticleId IdType="pubmed">28714393</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill C., Guarner F., Reid G., Gibson G.R., Merenstein D.J., Pot B., Morelli L., Canani R.B., Flint H.J., Salminen S., et al. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat. Rev. Gastroenterol. Hepatol. 2014;11:506&#x2013;514. doi: 10.1038/nrgastro.2014.66.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrgastro.2014.66</ArticleId><ArticleId IdType="pubmed">24912386</ArticleId></ArticleIdList></Reference><Reference><Citation>Jastrz&#x105;b R., Graczyk D., Siedlecki P. Molecular and Cellular Mechanisms Influenced by Postbiotics. Int. J. Mol. Sci. 2021;22:13475. doi: 10.3390/ijms222413475.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms222413475</ArticleId><ArticleId IdType="pmc">PMC8707144</ArticleId><ArticleId IdType="pubmed">34948270</ArticleId></ArticleIdList></Reference><Reference><Citation>Markowiak P., &#x15a;li&#x17c;ewska K. Effects of Probiotics, Prebiotics, and Synbiotics on Human Health. Nutrients. 2017;9:1021. doi: 10.3390/nu9091021.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu9091021</ArticleId><ArticleId IdType="pmc">PMC5622781</ArticleId><ArticleId IdType="pubmed">28914794</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Gioia D., Bozzi Cionci N., Baffoni L., Amoruso A., Pane M., Mogna L., Gagg&#xec;a F., Lucenti M.A., Bersano E., Cantello R., et al. A prospective longitudinal study on the microbiota composition in amyotrophic lateral sclerosis. BMC Med. 2020;18:153. doi: 10.1186/s12916-020-01607-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-020-01607-9</ArticleId><ArticleId IdType="pmc">PMC7298784</ArticleId><ArticleId IdType="pubmed">32546239</ArticleId></ArticleIdList></Reference><Reference><Citation>Nataraj B.H., Ali S.A., Behare P.V., Yadav H. Postbiotics-parabiotics: The new horizons in microbial biotherapy and functional foods. Microb. Cell Fact. 2020;19:168. doi: 10.1186/s12934-020-01426-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12934-020-01426-w</ArticleId><ArticleId IdType="pmc">PMC7441679</ArticleId><ArticleId IdType="pubmed">32819443</ArticleId></ArticleIdList></Reference><Reference><Citation>Song L., Gao Y., Zhang X., Le W. Galactooligosaccharide improves the animal survival and alleviates motor neuron death in SOD1G93A mouse model of amyotrophic lateral sclerosis. Neuroscience. 2013;246:281&#x2013;290. doi: 10.1016/j.neuroscience.2013.05.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2013.05.002</ArticleId><ArticleId IdType="pubmed">23673277</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitzgerald K.C., O&#x2019;Reilly &#xc9;.J., Falcone G.J., McCullough M.L., Park Y., Kolonel L.N., Ascherio A. Dietary omega-3 Polyunsaturated Fatty Acid Intake and Risk for Amyotrophic Lateral Sclerosis. JAMA Neurol. 2014;71:1102&#x2013;1110. doi: 10.1001/jamaneurol.2014.1214.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2014.1214</ArticleId><ArticleId IdType="pmc">PMC4160351</ArticleId><ArticleId IdType="pubmed">25023276</ArticleId></ArticleIdList></Reference><Reference><Citation>Yip P.K., Pizzasegola C., Gladman S., Biggio M.L., Marino M., Jayasinghe M., Ullah F., Dyall S.C., Malaspina A., Bendotti C., et al. The omega-3 fatty acid eicosapentaenoic acid accelerates disease progression in a model of amyotrophic lateral sclerosis. PLoS ONE. 2013;8:e61626. doi: 10.1371/journal.pone.0061626.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0061626</ArticleId><ArticleId IdType="pmc">PMC3631166</ArticleId><ArticleId IdType="pubmed">23620776</ArticleId></ArticleIdList></Reference><Reference><Citation>Chico L., Ienco E.C., Bisordi C., Lo Gerfo A., Petrozzi L., Petrucci A., Mancuso M., Siciliano G. Amyotrophic Lateral Sclerosis and Oxidative Stress: A Double-Blind Therapeutic Trial After Curcumin Supplementation. CNS Neurol. Disord. Drug Targets. 2018;17:767&#x2013;779. doi: 10.2174/1871527317666180720162029.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1871527317666180720162029</ArticleId><ArticleId IdType="pubmed">30033879</ArticleId></ArticleIdList></Reference><Reference><Citation>Wegh C.A.M., Geerlings S.Y., Knol J., Roeselers G., Belzer C. Postbiotics and Their Potential Applications in Early Life Nutrition and Beyond. Int. J. Mol. Sci. 2019;20:4673. doi: 10.3390/ijms20194673.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20194673</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>